Latest Ebola News
Current reporting and updates on Ebola virus disease from verified news sources. Updated daily. View archived news →
Last updated: November 12, 2026 · Checked for new stories November 15, 2026
-
Ebola tops 11,000 cases in Congo's deadliest outbreak
Congo's Ebola outbreak has topped 11,000 cases, the government said Wednesday, a stark figure that underscores the severity of the situation as the country grapples with the relentless spread of the disease.
-
UK doctor infected with Ebola being treated at London hospital
-
British Ebola patient evacuated from DR Congo arrives at London hospital
Doctor who was helping response to outbreak in Africa taken to specialist isolation unit at Royal Free hospital A British doctor who tested positive for Ebola while working in the Democratic Republic of the Congo has returned to the UK for specialist treatment. The patient, whose…
-
British healthcare worker with Ebola evacuated from DR Congo to UK
Patient is in stable condition and will be transferred to a specialist ‘high consequence’ infectious disease unit A British healthcare worker with Ebola is being evacuated from the Democratic Republic of the Congo to the UK for medical treatment, it has been confirmed. “A…
-
Asa Tribe barred from England Lions tour under Ebola rules after Kenya trip
Glamorgan opener played for Jersey in Kenya last month Entry ban brought in by St Kitts and Nevis government The Glamorgan opener Asa Tribe has been barred from joining the England Lions tour of the Caribbean following a visit to Kenya and concerns over the recent outbreak of…
-
Africa’s ‘unprecedented’ Ebola outbreak could reach UK, says top health official
Jean Kaseya, of the Africa CDC, warns of the illness spreading like Covid unless more funding is secured to increase preparedness and possible treatment The “unprecedented” spread of the Ebola outbreak means it could reach the UK and other countries, according to one of Africa’s…
Current Outbreak
Active outbreak tracker. Always verify with WHO Disease Outbreak News.
DRC — Bundibugyo Virus (2026)
What Changed Since Our Last Review — and What Did Not
Changed (September 12 → October 31, 2026): DRC's confirmed count rose from 7,200 to 10,467 and deaths from 3,475 to 5,103 (CDC) — about 470 new confirmed cases a week on average (our calculation). Confirmed cases now span eight provinces, with Sud-Ubangi and Nord-Ubangi added. The outbreak reached two more countries: Kenya confirmed an imported case on October 6 and had nine cases and two deaths in Nairobi by October 23, all linked to that traveler; Nigeria reported its first case on October 20. CDC still assesses the risk to the United States as low.
Not changed: no approved vaccine or treatment for Bundibugyo virus; no case in the United States; CDC's domestic risk assessment of "low"; and — per CDC's own operational review of August 21 — an outbreak whose indicators "indicate uncontrolled expansion." Every figure above has a date and a source on the 2026 outbreak page, which also notes where CDC's and WHO's counts differ.
Explore All Topics
In-depth, evidence-based coverage of every major aspect of Ebola virus disease.
2026 Outbreak
Active DRC outbreak — Bundibugyo virus, second-largest ever. WHO PHEIC declared.
Read more →Ebola Symptoms
Dry and wet phases, how often each symptom actually occurs, and what predicts death.
Read more →Transmission
How Ebola spreads through body fluids — and how it does NOT spread.
Read more →Treatment & Vaccines
FDA-approved antibodies (Inmazeb, Ebanga) and the one licensed vaccine (Ervebo) — all for Zaire virus, with the trial numbers.
Read more →Bundibugyo vs Zaire
Why every licensed Ebola vaccine and antibody targets the wrong species for 2026.
Read more →Life After Ebola
What survivors have more of than uninfected controls, the first-year death rate, relapse, and the Bundibugyo evidence.
Read more →What US Treatment Cost
What Nebraska and Emory said it cost per patient in 2014, in sworn testimony and 2026 dollars — and why the figure Google shows is a setup cost, not a bill.
Read more →Outbreak History
Complete timeline from the 1976 first identification through 2026.
Read more →For Healthcare Workers
PPE requirements, isolation protocols, testing, and mandatory reporting.
Read more →Isolation Precautions
Contact and droplet, not airborne — the rule, the disease matrix nurses are tested on, and 80 practice questions.
Read more →Travel Risk
CDC Level 4 notice for Ituri and North Kivu, the 21-day U.S. entry rule, and what to do after travel.
Read more →Prevention
How to prevent Ebola exposure — hand hygiene, PPE, bushmeat, and travel precautions.
Read more →Ebola in the U.S.
Every U.S. case (4 diagnosed, 11 treated, 2 deaths), CDC's 2026 risk reasoning, and the entry rules.
Read more →Misinformation
Debunking the airborne myth, secret cures, vaccine conspiracy theories.
Read more →Research
Landmark peer-reviewed studies — PALM trial, Ervebo, virology, epidemiology.
Read more →Best Ebola Books
The Hot Zone, Crisis in the Red Zone, Spillover, and more — with Amazon links.
Read more →Risk Perspective
How Ebola compares to 14 other viruses on exposure, hospitalization, and death.
Read more →Why "Which Ebola" Is the Question That Matters in 2026
Six species of orthoebolavirus are recognised; three cause large outbreaks. Every licensed countermeasure — the Ervebo vaccine and the Inmazeb and Ebanga antibody treatments — was built against Ebola (Zaire) virus, which caused every large outbreak before this one. The 2026 outbreak is Bundibugyo virus, a species that had produced only two small outbreaks (Uganda 2007, DRC 2012) before this year. The FDA labels for both antibodies state that efficacy "has not been established for other species"; CDC's clinical guidance (May 27, 2026) says there are no FDA-approved treatments or vaccines for Bundibugyo virus; and WHO's SAGE concluded on August 19, 2026 that Ervebo's efficacy against it "remains unknown."
The species also sets expectations for lethality. A 2024 meta-analysis of 42 outbreaks put the pooled case fatality rate at 66.6% for Zaire virus, 48.5% for Sudan virus and 32.8% (95% CI 25.8–40.2) for Bundibugyo virus (Izudi et al., J Infect Public Health). The 2026 outbreak's crude rate of 48% sits above the Bundibugyo interval — while the 20 confirmed cases treated promptly in Uganda had a fatality rate of 10% (CDC MMWR, September 10, 2026). Whether the gap is timing of care, undetected mild cases, or the virus is not settled. Treatment & vaccines → · Case fatality by species →
Symptoms: What the Case Series Show, Not Just the List
Ebola begins with a "dry" phase — fever, headache, muscle and joint pain, fatigue — and progresses in most patients to a "wet" phase of vomiting and diarrhea (CDC). The early symptoms are the same as malaria's, which is why exposure history matters more than the symptoms themselves. In the largest series ever recorded, the WHO Ebola Response Team's analysis of the 2014 epidemic in NEJM, fever was recorded in 87.1% of patients, fatigue in 76.4%, vomiting in 67.6% and diarrhea in 65.6% — and specific bleeding signs in fewer than 6% each. In the first clinical description of the 2026 species, all 18 Bundibugyo patients admitted to Uganda's treatment unit had fever, 83% headache and 78% muscle pain; the three who died were the only ones who bled (CDC MMWR). Bleeding is uncommon, and when it appears it is a marker of dying, not a first sign. The 21-day monitoring rule rests on a mean incubation of 11.4 days with about 95% of cases falling inside 21 (NEJM 2014). Symptom frequencies, what predicts death, and the incubation evidence →
Transmission and Prevention: What Actually Reduced Spread
Ebola spreads by direct contact with the body fluids of someone who is sick or has died of it — not through the air, and not before symptoms (CDC; WHO). Its reproduction number in 2014 was between 1.7 and 2.0 by country, with a serial interval of about 15 days (WHO Ebola Response Team, NEJM) — lethal, but not especially contagious, and slow enough for contact tracing to work. The transmission-chain data say which precautions matter most: in Guinea, unsafe burial was associated with 1.82 times as many onward infections and treatment-unit care cut onward transmission from patients who died by 38% (Robert et al., Am J Epidemiol 2019); in the 2007 Bundibugyo outbreak, handling the dead without protection carried an adjusted odds ratio of 3.83 (Wamala et al., Emerg Infect Dis 2010). CDC's August 2026 review found only 49% of affected health zones had a safe-burial team and 59% of confirmed deaths were occurring outside a treatment unit. Survivors can carry the virus in semen for many months — 62% of men tested at 4–6 months and 4% at 16–18 months in the Sierra Leone cohort (Deen et al., NEJM 2017). Transmission, with the numbers → · Prevention, with the evidence → · For healthcare workers →
Ebola in the United States, and the Rules for Travelers
Four people have ever been diagnosed with Ebola on U.S. soil, all in 2014; eleven were treated here and two died (CDC). Of the 27 patients treated in U.S. and European hospitals in 2014–15, 81% were healthcare workers and 81.5% survived with intensive supportive care (Uyeki et al., NEJM 2016). In 2026 CDC rates the domestic risk as low — likelihood "extremely low," impact high, per its June 11 MMWR assessment, reaffirmed September 8 — and no case has arrived. The rule that matters for travelers: anyone who has been in DRC within 21 days, U.S. citizens included, cannot board a commercial flight to the United States; arrivals from Uganda or South Sudan are routed through three designated airports for screening. CDC's travel notice for Ituri and North Kivu is Level 4, "avoid all travel." WHO, for its part, advises against any travel or trade restriction — the two agencies disagree, and U.S. rules govern the flight home. Ebola in the U.S. → · Travel risk and entry rules →
Where the Numbers Come From — and What Is Not Known
Every figure on this site traces to a primary source read directly, with its date: CDC's situation summary and the public data file behind its outbreak chart; WHO's fortnightly Disease Outbreak News; FDA prescribing information; CDC's MMWR; and peer-reviewed papers cited by DOI. Where CDC and WHO differ — on the sixth affected province, on the 2007 outbreak's case count, on when Uganda's outbreak ended — both are given. Where a number is ours, it is labelled "our calculation" with the arithmetic shown. And where nothing reliable exists, the page says so rather than filling the gap:
- No incubation-period or transmission parameters specific to the 2026 virus have been published in a peer-reviewed primary analysis.
- No result from the PARTNERS treatment trial and no efficacy signal from the Ervebo research-protocol vaccination.
- No current health-worker infection count — WHO last restated it for August 9 (at least 155 cases, 45 deaths).
- No economic-cost estimate for the 2026 outbreak from the World Bank, WHO or CDC.
- No count of Americans under monitoring or tested in 2026 — CDC describes the process, not the numbers.
Compared to what? Ebola is extremely lethal and extremely rare. For how it compares with 14 other viruses on exposure, hospitalisation and death, see the network's Virus Risk Perspective and this site's Ebola risk perspective. Corrections made during this review — eleven of them, from a fever threshold to a withdrawn vaccine authorisation — are on the corrections page and stated on the pages they affect.
Sources & References
- Centers for Disease Control and Prevention. Ebola Outbreak: Current Situation. Page dated September 14, 2026. cdc.gov/ebola/situation-summary
- Centers for Disease Control and Prevention. Clinical Guidance for Ebola Disease. May 27, 2026. cdc.gov/ebola/hcp/clinical-guidance
- Centers for Disease Control and Prevention, Center for Forecasting and Outbreak Analytics. Risk to the U.S. Population from the 2026 Ebola Disease Outbreak Caused by Bundibugyo Virus. Updated September 8, 2026. cdc.gov/cfa-qualitative-assessments
- World Health Organization. Disease Outbreak News 617: Ebola disease caused by Bundibugyo virus — DRC. September 10, 2026. who.int/…/2026-DON617
- Mutegeki M, et al. and Kabasele D, et al. Notes from the Field. MMWR 2026;75(35):551–556. doi:10.15585/mmwr.mm7535e1
- WHO Ebola Response Team. Ebola virus disease in West Africa — the first 9 months. N Engl J Med 2014;371:1481–95. doi:10.1056/NEJMoa1411100
- Izudi J, Bajunirwe F. Case fatality rate for Ebola disease, 1976–2022: A meta-analysis. J Infect Public Health 2024;17:25–34. doi:10.1016/j.jiph.2023.10.020
- Robert A, et al. Determinants of Transmission Risk During the Late Stage of the West African Ebola Epidemic. Am J Epidemiol 2019;188:1319–27. doi:10.1093/aje/kwz090
- Uyeki TM, et al. Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med 2016;374:636–46. doi:10.1056/NEJMoa1504874
- U.S. Food and Drug Administration. INMAZEB and EBANGA prescribing information; ERVEBO. fda.gov/vaccines-blood-biologics/ervebo